These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

401 related articles for article (PubMed ID: 16264990)

  • 1. New concepts for phase I trials: evaluating new drugs combined with radiation therapy.
    Deutsch E; Soria JC; Armand JP
    Nat Clin Pract Oncol; 2005 Sep; 2(9):456-65. PubMed ID: 16264990
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exploitable mechanisms for combining drugs with radiation: concepts, achievements and future directions.
    Bentzen SM; Harari PM; Bernier J
    Nat Clin Pract Oncol; 2007 Mar; 4(3):172-80. PubMed ID: 17327857
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New radiosensitizing regimens, drugs, prodrugs, and candidates.
    Vallerga AK; Zarling DA; Kinsella TJ
    Clin Adv Hematol Oncol; 2004 Dec; 2(12):793-805. PubMed ID: 16166960
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Perspectives in biological modulation of radiotherapy].
    Deutsch E; Huguet F
    Bull Cancer; 2005 Jan; 92(1):90-6. PubMed ID: 16123013
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biologic basis for combining drugs with radiation.
    Wilson GD; Bentzen SM; Harari PM
    Semin Radiat Oncol; 2006 Jan; 16(1):2-9. PubMed ID: 16378901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Should positive phase III clinical trial data be required before proton beam therapy is more widely adopted? No.
    Suit H; Kooy H; Trofimov A; Farr J; Munzenrider J; DeLaney T; Loeffler J; Clasie B; Safai S; Paganetti H
    Radiother Oncol; 2008 Feb; 86(2):148-53. PubMed ID: 18237800
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New paradigm in dose-finding trials: patient-specific dosing and beyond phase I.
    Rogatko A; Babb JS; Tighiouart M; Khuri FR; Hudes G
    Clin Cancer Res; 2005 Aug; 11(15):5342-6. PubMed ID: 16061846
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Translational research offers individually tailored treatments for cancer patients.
    Bartelink H; Begg AC; Martin JC; van Dijk M; Moonen L; van 't Veer LJ; Van de Vaart P; Verheij M
    Cancer J Sci Am; 2000; 6(1):2-10. PubMed ID: 10696731
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
    Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
    Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased risk of high-grade dermatologic toxicities with radiation plus epidermal growth factor receptor inhibitor therapy.
    Tejwani A; Wu S; Jia Y; Agulnik M; Millender L; Lacouture ME
    Cancer; 2009 Mar; 115(6):1286-99. PubMed ID: 19170238
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Designing dose-escalation trials with late-onset toxicities using the time-to-event continual reassessment method.
    Normolle D; Lawrence T
    J Clin Oncol; 2006 Sep; 24(27):4426-33. PubMed ID: 16983110
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biologic and clinical developments of cisplatin combined with radiation: concepts, utility, projections for new trials, and the emergence of carboplatin.
    Coughlin CT; Richmond RC
    Semin Oncol; 1989 Aug; 16(4 Suppl 6):31-43. PubMed ID: 2669136
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiation sensitizers: a selective review of molecules targeting DNA and non-DNA targets.
    Kvols LK
    J Nucl Med; 2005 Jan; 46 Suppl 1():187S-90S. PubMed ID: 15653668
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Strategies for enhancing viral-based gene therapy using ionizing radiation.
    Chmura SJ; Advani SJ; Kufe DW; Weichselbaum RR
    Radiat Oncol Investig; 1999; 7(5):261-9. PubMed ID: 10580895
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oxygen delivery: implications for the biology and therapy of solid tumors.
    Rockwell S
    Oncol Res; 1997; 9(6-7):383-90. PubMed ID: 9406244
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A recent trial of chemo-radiation with S-1 against gastric cancer].
    Saikawa Y; Kiyota T; Nakamura R; Wada N; Yoshida M; Kubota T; Kumai K; Shigematsu N; Kubo A; Kitajima M
    Gan To Kagaku Ryoho; 2006 Jun; 33 Suppl 1():99-105. PubMed ID: 16897982
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence-based radiation oncology in head and neck squamous cell carcinoma.
    Corvò R
    Radiother Oncol; 2007 Oct; 85(1):156-70. PubMed ID: 17482300
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risks and benefits associated with novel phase 1 oncology trial designs.
    Koyfman SA; Agrawal M; Garrett-Mayer E; Krohmal B; Wolf E; Emanuel EJ; Gross CP
    Cancer; 2007 Sep; 110(5):1115-24. PubMed ID: 17628485
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination of vascular endothelial growth factor receptor/platelet-derived growth factor receptor inhibition markedly improves radiation tumor therapy.
    Timke C; Zieher H; Roth A; Hauser K; Lipson KE; Weber KJ; Debus J; Abdollahi A; Huber PE
    Clin Cancer Res; 2008 Apr; 14(7):2210-9. PubMed ID: 18381963
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.